Whereas some studies could not detect a correlation between serum levels of sclerostin and the extent of cardiovascular calcification in patients in CKD stage 5D [82,83], others found a positive or negative correlation with calcification extent in CKD [81]. This evidence concerns the gene SOST and chronic kidney disease.